TELUS reported strong Q1 '25 results, exceeding peers in revenue and EBITDA growth driven by TELUS Health and Agriculture, and announced a 7% dividend increase while extending its growth program to 2028. The company is considered attractively valued due to superior telecom growth, operational efficiencies, and a 7.5% dividend yield, leading to a 'buy' rating despite sector risks, supported by potential asset monetization and margin expansion.
TELUS (T:CA, TU) demonstrated robust financial performance in its reported Q1 '25 results, outperforming peers in both revenue and EBITDA growth, with notable contributions from its TELUS Health and TELUS Agriculture business units. This performance supported the company's announcement of a 7% increase in its dividend and the extension of its dividend growth program through 2028, reflecting management's confidence in sustained long-term cash flow generation and the sustainability of its shareholder distributions. The company is presented as attractively valued compared to its industry counterparts, a valuation justified by its superior growth in the core telecommunications segment, ongoing operational efficiencies, and a compelling, sector-leading dividend yield of 7.5%. Despite inherent sector risks and prevailing competitive pressures, the outlook is supported by potential asset monetization strategies and continued margin expansion, aligning with the provided strongly positive sentiment score of 0.85.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment